Articles About
Mark Rasenick
Mark Rasenick PhD
Dr. Rasenick’s work has focused on G protein signaling in the nervous system and the relationship of neurotransmitter activation to rapid modification of the cytoskeleton. He has been particularly interested in how G proteins and the cytoskeleton work in concert to modify synaptic shape and ...
Contributions
NAMED IN THE TOP #100 IN 2016 FOR DISCOVER MAGAZINE
Discover Magazine ranks its Top #100 science stories each year. Considered by the publication to be the “best in science,” Discover named an article profiling the work of Dr. Mark Rasenick, part of UI CDR Leadership, published in July 2016 for its annual list. Read More
Animated Video on Clinical Depression is a Tool for Outreach
Depression is among the most common mental health conditions affecting young adults. In a 2015 survey of 43,210 undergraduate students across 72 U.S. colleges and universities, 18.2 percent of students screened positive for depressive symptoms and 7.8 percent reported serious thoughts of suicide. Read More
Executives’ Club of Chicago Nominates UI CDR as “INNOVATOR OF THE YEAR”
UI CDR is honored to be nominated for Executives’ Club of Chicago “Innovator of the Year” award. Since 2013, this honor has been awarded to an individual or company in greater Chicago whose new product, service, process or business model has resulted in organic growth and measurable economic benefit to the region. Read More
Why do antidepressants take so long to work?
An episode of major depression can be crippling, impairing the ability to sleep, work, or eat. But the drugs available to treat depression can take weeks or even months to start working. Researchers have discovered one reason the drugs take so long to work, and their finding could help scientists develop faster-acting drugs in the future. Read More
Simple blood test could show whether an antidepressant is working
The researchers at the University of Illinois in Chicago have found that the change in location of the protein occurs within days of taking the drug. Read More
Why Antidepressants Are So Slow to Act
One of the top 100 stories of 2016 investigates why it takes weeks for antidepressents to work. Read More
The ‘Untreatables’: When Modern Psychiatry Can’t Help
Many of these patients who struggle and sometimes never successfully find relief have been dubbed “untreatable.” In recent years, researchers have dedicated a lot of resources towards finding just what makes treatment-resistant patients different from those that respond well to treatment. The answer, they’ve found, lies beyond the current reaches of psychiatry and biology. Slowly, experts are realizing that medicine need to reorient how it treats mental illness in order to help patients in this group to get their lives back. Read More
As Cuba-US Relations Thaw, Potential Medical Advances Grow
Recent US steps toward normalizing relations with Cuba after 5 decades may open doors in both countries to medical advances. Read More